Close Menu

NEW YORK (GenomeWeb) – Qiagen said today that its Artus T. vaginalis QS-RGQ kit has received CE marking and is now commercially available in Europe.

The real-time PCR assay is designed for the qualitative detection of Trichomonas vaginalis DNA purified from clinician-collected vaginal swabs, endocervical swabs, and urine samples from symptomatic and asymptomatic patients.

The test is configured for use with the QiaSymphony RGQ system, which comprises the QiaSymphony SP/AS (sample prep/assay setup) and Rotor-Gene Q instruments.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.